Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
September 13, 2022
Patent Application Number
16413557
Date Filed
May 15, 2019
Patent Citations
Patent Primary Examiner
Anti-TIGIT antibodies and antigen binding fragments thereof that inhibit TIGIT-mediated signalling are provided, together with combinations comprising said antibodies or antigen binding fragments thereof and methods for their use.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
